Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF-187 exhibit a functional dominant Tyr165Ser mutation in the Walker A ATP binding site of topoisomerase II alpha. (Q44014803)
Jump to navigation
Jump to search
scientific article published in June 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF-187 exhibit a functional dominant Tyr165Ser mutation in the Walker A ATP binding site of topoisomerase II alpha. |
scientific article published in June 2002 |
Statements
Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF-187 exhibit a functional dominant Tyr165Ser mutation in the Walker A ATP binding site of topoisomerase II alpha (English)
Lars H Jensen
Axelle Renodon-Corniere
Tina K Sorensen
Peter B Jensen
Maxwell Sehested
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference